MAP PHARMACEUTICALS, INC. Net Income
MAP PHARMACEUTICALS, INC. reported Net Income of -$12.62 million for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2012-11-06
- MAP PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2012-09-30 was -$12.62M, a 254.25% decline year-over-year.
- MAP PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2012-06-30 was -$13.29M.
- MAP PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2012-03-31 was -$17.84M.
- MAP PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2011-12-31 was -$13.82M.
- MAP PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2011 was -$32.94M.
- MAP PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2010 was -$54.67M.
- MAP PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2009 was -$9.00M.
- MAP PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2008 was -$72.93M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 96 month | Net Income (Loss) Attributable to Parent 96 month as first filed | Net Income (Loss) Attributable to Parent 99 month | Net Income (Loss) Attributable to Parent 99 month as first filed | Net Income (Loss) Attributable to Parent 102 month | Net Income (Loss) Attributable to Parent 105 month | Net Income (Loss) Attributable to Parent 108 month | Net Income (Loss) Attributable to Parent 111 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | -$12.62M 10-Q · filed 2012-11-06 | -$25.91M derived: sum of 2 quarters · filed 2012-11-06 | -$43.76M 10-Q · filed 2012-11-06 | -$57.58M derived: sum of 4 quarters · filed 2012-11-06 | -$304.24M 10-Q · filed 2012-11-06 | ||||||||||
| 2012-06-30 | -$13.29M 10-Q · filed 2012-07-27 | -$31.14M 10-Q · filed 2012-07-27 | -$44.95M derived: sum of 3 quarters · filed 2012-07-27 | -$36.77M derived: sum of 4 quarters · filed 2012-11-06 | -$291.62M 10-Q · filed 2012-07-27 | ||||||||||
| 2012-03-31 | -$17.84M 10-Q · filed 2012-05-08 | -$31.66M derived: sum of 2 quarters · filed 2012-05-08 | -$23.48M derived: sum of 3 quarters · filed 2012-11-06 | -$34.78M derived: sum of 4 quarters · filed 2012-11-06 | -$278.33M 10-Q · filed 2012-05-08 | ||||||||||
| 2011-12-31 | -$13.82M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$5.64M derived: sum of 2 quarters · filed 2012-11-06 | -$16.94M derived: sum of 3 quarters · filed 2012-11-06 | -$32.94M 10-K · filed 2012-03-30 | -$260.49M 10-K · filed 2012-03-30 | ||||||||||
| 2011-09-30 | $8.18M 10-Q · filed 2012-11-06 | $11.21M 10-Q · filed 2011-11-08 | -$3.12M derived: sum of 2 quarters · filed 2012-11-06 | -$19.12M 10-Q · filed 2012-11-06 | $20.18M 10-Q · filed 2011-11-08 | -$33.07M derived: sum of 4 quarters · filed 2012-11-06 | -$246.67M 10-Q/A · filed 2012-03-30 | -$207.36M 10-Q · filed 2011-11-08 | |||||||
| 2011-06-30 | -$11.30M 10-Q · filed 2012-07-27 | -$8.63M 10-Q · filed 2011-08-08 | -$27.30M 10-Q · filed 2012-07-27 | $8.98M 10-Q · filed 2011-08-08 | -$41.25M derived: sum of 3 quarters · filed 2012-07-27 | -$55.43M derived: sum of 4 quarters · filed 2012-07-27 | -$254.85M 10-Q/A · filed 2012-03-30 | -$218.57M 10-Q · filed 2011-08-08 | |||||||
| 2011-03-31 | -$16.00M 10-Q · filed 2012-05-08 | -$29.95M derived: sum of 2 quarters · filed 2012-05-08 | -$44.13M derived: sum of 3 quarters · filed 2012-05-08 | -$56.62M derived: sum of 4 quarters · filed 2012-05-08 | |||||||||||
| 2010-12-31 | -$13.95M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-30 | -$28.13M derived: sum of 2 quarters · filed 2012-03-30 | -$40.62M derived: sum of 3 quarters · filed 2012-03-30 | -$54.67M 10-K · filed 2012-03-30 | |||||||||||
| 2010-09-30 | -$14.18M 10-Q/A · filed 2012-03-30 | -$26.67M derived: sum of 2 quarters · filed 2012-03-30 | -$40.73M 10-Q/A · filed 2012-03-30 | ||||||||||||
| 2010-06-30 | -$12.49M 10-Q/A · filed 2012-03-30 | -$26.55M 10-Q/A · filed 2012-03-30 | |||||||||||||
| 2009-12-31 | -$9.00M 10-K · filed 2012-03-30 | ||||||||||||||
| 2008-12-31 | -$72.93M 10-K · filed 2012-03-30 | ||||||||||||||
| 2007-12-31 | -$40.06M 10-K · filed 2012-03-30 | ||||||||||||||
| 2006-12-31 | -$25.81M 10-K · filed 2012-03-30 | ||||||||||||||
| 2005-12-31 | -$16.25M 10-K · filed 2012-03-30 | ||||||||||||||
| 2004-12-31 | -$8.83M 10-K · filed 2012-03-30 |